186 related articles for article (PubMed ID: 25389051)
21. Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas.
Lassaletta A; Zapotocky M; Mistry M; Ramaswamy V; Honnorat M; Krishnatry R; Guerreiro Stucklin A; Zhukova N; Arnoldo A; Ryall S; Ling C; McKeown T; Loukides J; Cruz O; de Torres C; Ho CY; Packer RJ; Tatevossian R; Qaddoumi I; Harreld JH; Dalton JD; Mulcahy-Levy J; Foreman N; Karajannis MA; Wang S; Snuderl M; Nageswara Rao A; Giannini C; Kieran M; Ligon KL; Garre ML; Nozza P; Mascelli S; Raso A; Mueller S; Nicolaides T; Silva K; Perbet R; Vasiljevic A; Faure Conter C; Frappaz D; Leary S; Crane C; Chan A; Ng HK; Shi ZF; Mao Y; Finch E; Eisenstat D; Wilson B; Carret AS; Hauser P; Sumerauer D; Krskova L; Larouche V; Fleming A; Zelcer S; Jabado N; Rutka JT; Dirks P; Taylor MD; Chen S; Bartels U; Huang A; Ellison DW; Bouffet E; Hawkins C; Tabori U
J Clin Oncol; 2017 Sep; 35(25):2934-2941. PubMed ID: 28727518
[TBL] [Abstract][Full Text] [Related]
22. cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAF
Ellison DW; Hawkins C; Jones DTW; Onar-Thomas A; Pfister SM; Reifenberger G; Louis DN
Acta Neuropathol; 2019 Apr; 137(4):683-687. PubMed ID: 30848347
[No Abstract] [Full Text] [Related]
23. Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact.
Cabral de Carvalho Corrêa D; Tesser-Gamba F; Dias Oliveira I; Saba da Silva N; Capellano AM; de Seixas Alves MT; Dastoli PA; Cavalheiro S; Caminada de Toledo SR
J Cancer Res Clin Oncol; 2022 Jan; 148(1):107-119. PubMed ID: 34626238
[TBL] [Abstract][Full Text] [Related]
24. Comparison of 2 monoclonal antibodies for immunohistochemical detection of BRAF V600E mutation in malignant melanoma, pulmonary carcinoma, gastrointestinal carcinoma, thyroid carcinoma, and gliomas.
Routhier CA; Mochel MC; Lynch K; Dias-Santagata D; Louis DN; Hoang MP
Hum Pathol; 2013 Nov; 44(11):2563-70. PubMed ID: 24071017
[TBL] [Abstract][Full Text] [Related]
25. Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location.
Karremann M; Gielen GH; Hoffmann M; Wiese M; Colditz N; Warmuth-Metz M; Bison B; Claviez A; van Vuurden DG; von Bueren AO; Gessi M; Kühnle I; Hans VH; Benesch M; Sturm D; Kortmann RD; Waha A; Pietsch T; Kramm CM
Neuro Oncol; 2018 Jan; 20(1):123-131. PubMed ID: 29016894
[TBL] [Abstract][Full Text] [Related]
26. The H3.3 K27M mutation results in a poorer prognosis in brainstem gliomas than thalamic gliomas in adults.
Feng J; Hao S; Pan C; Wang Y; Wu Z; Zhang J; Yan H; Zhang L; Wan H
Hum Pathol; 2015 Nov; 46(11):1626-32. PubMed ID: 26297251
[TBL] [Abstract][Full Text] [Related]
27. KIAA1549:BRAF fusion gene in pediatric brain tumors of various histogenesis.
Antonelli M; Badiali M; Moi L; Buttarelli FR; Baldi C; Massimino M; Sanson M; Giangaspero F
Pediatr Blood Cancer; 2015 Apr; 62(4):724-7. PubMed ID: 25382612
[TBL] [Abstract][Full Text] [Related]
28. Autophagy-related protein expression was associated with BRAF V600E mutation in epilepsy associated glioneuronal tumors.
Shen CH; Zhang YX; Xu JH; Zhu QB; Zhu JM; Guo Y; Ding Y; Wang S; Ding MP
Epilepsy Res; 2017 Sep; 135():123-130. PubMed ID: 28667867
[TBL] [Abstract][Full Text] [Related]
29. Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma.
López G; Oberheim Bush NA; Berger MS; Perry A; Solomon DA
Acta Neuropathol Commun; 2017 May; 5(1):38. PubMed ID: 28506301
[No Abstract] [Full Text] [Related]
30. Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expression.
Lopez GY; Oberheim Bush NA; Phillips JJ; Bouffard JP; Moshel YA; Jaeckle K; Kleinschmidt-DeMasters BK; Rosenblum MK; Perry A; Solomon DA
Acta Neuropathol; 2017 Dec; 134(6):961-963. PubMed ID: 29063183
[No Abstract] [Full Text] [Related]
31. Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations.
Schüller U; Iglauer P; Dorostkar MM; Mawrin C; Herms J; Giese A; Glatzel M; Neumann JE
Acta Neuropathol; 2021 Feb; 141(2):323-325. PubMed ID: 33433639
[No Abstract] [Full Text] [Related]
32. A Case Series Characterizing Pilomyxoid Astrocytomas in Childhood.
Rosenfeld A; Etzl M; Lee D; Miller J; Carpenteri D; Shafron D; Kaplan A
J Pediatr Hematol Oncol; 2016 Mar; 38(2):e63-6. PubMed ID: 26886222
[TBL] [Abstract][Full Text] [Related]
33. BRAF inhibitors in BRAF-V600 mutated primary neuroepithelial brain tumors.
Preusser M; Bienkowski M; Birner P
Expert Opin Investig Drugs; 2016; 25(1):7-14. PubMed ID: 26536389
[TBL] [Abstract][Full Text] [Related]
34. Targeted detection of genetic alterations reveal the prognostic impact of H3K27M and MAPK pathway aberrations in paediatric thalamic glioma.
Ryall S; Krishnatry R; Arnoldo A; Buczkowicz P; Mistry M; Siddaway R; Ling C; Pajovic S; Yu M; Rubin JB; Hukin J; Steinbok P; Bartels U; Bouffet E; Tabori U; Hawkins C
Acta Neuropathol Commun; 2016 Aug; 4(1):93. PubMed ID: 27577993
[TBL] [Abstract][Full Text] [Related]
35. FGFR1 N546K and H3F3A K27M mutations in a diffuse leptomeningeal tumour with glial and neuronal markers.
Dyson K; Rivera-Zengotita M; Kresak J; Weaver K; Stover B; Fort J; Rahman M; Pincus DW; Sayour EJ
Histopathology; 2016 Oct; 69(4):704-7. PubMed ID: 27061725
[No Abstract] [Full Text] [Related]
36. Pediatric gliomas with CRAF fusions may require combination treatment.
Printz C
Cancer; 2016 Apr; 122(8):1148. PubMed ID: 27061517
[No Abstract] [Full Text] [Related]
37. BRAF V600E mutation identifies a subset of low-grade diffusely infiltrating gliomas in adults.
Chi AS; Batchelor TT; Yang D; Dias-Santagata D; Borger DR; Ellisen LW; Iafrate AJ; Louis DN
J Clin Oncol; 2013 May; 31(14):e233-6. PubMed ID: 23547069
[No Abstract] [Full Text] [Related]
38. K27M midline gliomas display malignant progression by imaging and histology.
Vettermann FJ; Neumann JE; Suchorska B; Bartenstein P; Giese A; Dorostkar MM; Albert NL; Schüller U
Neuropathol Appl Neurobiol; 2017 Aug; 43(5):458-462. PubMed ID: 27997032
[No Abstract] [Full Text] [Related]
39. RAF gene fusions are specific to pilocytic astrocytoma in a broad paediatric brain tumour cohort.
Lawson AR; Tatevossian RG; Phipps KP; Picker SR; Michalski A; Sheer D; Jacques TS; Forshew T
Acta Neuropathol; 2010 Aug; 120(2):271-3. PubMed ID: 20454969
[No Abstract] [Full Text] [Related]
40. Frequent BRAF V600E Mutations in Metanephric Stromal Tumor.
Argani P; Lee J; Netto GJ; Zheng G; Tseh-Lin M; Park BH
Am J Surg Pathol; 2016 May; 40(5):719-22. PubMed ID: 26796506
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]